- ‘Echo’ Trailer Reveals Major Marvel Firsts: TV-MA Rating, Simultaneous Hulu Debut and Native American and Deaf Lead Variety
- ECHO Trailer Features Kingpin, Daredevil, And Bloody Violence As TV-MA Rating And Premiere Date Are Revealed ECHO Trailer Features Kingpin, Daredevil, And Bloody Violence As TV-MA Rating And Premiere Date Are Revealed CBM (Comic Book Movie)
- I Think Netflix Daredevil Fans Are Going To Be Really Happy With Echo After The Footage I Just Watched CinemaBlend
- ‘Echo’ Trailer Confirms at Least 4 History-Making Firsts for the MCU We Got This Covered
- Marvel Drops New Echo Trailer—All Episodes Streaming January 10 Gizmodo
- View Full Coverage on Google News
Tag Archives: rating
‘Five Nights at Freddy’s’ Director Defends PG-13 Rating and Tells Fans ‘Not to Expect’ R-Rated Cut: ‘We’re Sticking’ to the Rating – Variety
- ‘Five Nights at Freddy’s’ Director Defends PG-13 Rating and Tells Fans ‘Not to Expect’ R-Rated Cut: ‘We’re Sticking’ to the Rating Variety
- Five Nights at Freddy’s Set to Stick to PG-13 Rating, No Plans for an R-Rated Director’s Cut MovieWeb
- How The Five Nights At Freddy’s Movie Mashes Up The Game’s Story And Shot For A PG-13 Rating GameSpot
- Five Nights at Freddy’s Won’t Get an R-rated Cut IGN
- Designer of Five Nights at Freddy’s Pivoted From Religious Games The New York Times
- View Full Coverage on Google News
Polanski’s The Palace Faces a Harsh Reality Debuting with 0% Rotten Tomatoes Rating – MovieWeb
- Polanski’s The Palace Faces a Harsh Reality Debuting with 0% Rotten Tomatoes Rating MovieWeb
- Roman Polanski’s latest film The Palace scores shocking 0% on Rotten Tomatoes UNILAD
- ‘The Palace’ Review: Roman Polanski’s Dreadful Hotel Comedy Makes The Controversial Director A Laughing Stock – Venice Film Festival Deadline
- Roman Polanski’s The Palace debuts with a dismal 0% Rotten Tomatoes score Hindustan Times
- Roman Polanski Fails to Stir Up Venice Buzz as ‘The Palace’ Premieres to Meager Applause Variety
- View Full Coverage on Google News
Delta Air Lines On A Robust Trajectory: Morgan Stanley Reiterates Overweight Rating With Higher Price Tar – Benzinga
- Delta Air Lines On A Robust Trajectory: Morgan Stanley Reiterates Overweight Rating With Higher Price Tar Benzinga
- Delta Air Lines Stock: Strong Buy On Historic Earnings And Supercycle Growth (NYSE:DAL) Seeking Alpha
- Delta Air Lines Soars to New Heights: Can the Profit, Revenue Surge Last? | investing.com Investing.com
- Is Now The Time To Put Delta Air Lines (NYSE:DAL) On Your Watchlist? Yahoo Finance
- Cranky Weekly Review Presented by Oakland International Airport: Delta Gets Rich, Northern Pacific Gets Started, More – Cranky Flier Cranky Flier
- View Full Coverage on Google News
Sounds like Christopher Nolan’s Oppenheimer is really going to earn that “R” rating – The A.V. Club
- Sounds like Christopher Nolan’s Oppenheimer is really going to earn that “R” rating The A.V. Club
- Cillian Murphy Didn’t Join ‘Oppenheimer’ Cast Dinners Because ‘His Brain Was Just Too Full,’ Says Matt Damon Yahoo Entertainment
- ‘Oppenheimer’ Includes “Prolonged Full Nudity” Between Cillian Murphy and Florence Pugh — World of Reel Jordan Ruimy
- OPPENHEIMER (NEW) Film Cast INTERVIEWS: Cillian Murphy, Emily Blunt, Matt Damon & Christopher Nolan! Tara Hitchcock
- Cillian Murphy warns Oppenheimer ‘f**ks you up a little bit’ Yahoo Movies UK
- View Full Coverage on Google News
2023 NCAA DI Men’s Outdoor Track & Field Rating Index – Week 1 – U.S. Track & Field and Cross Country Coaches Association
- 2023 NCAA DI Men’s Outdoor Track & Field Rating Index – Week 1 U.S. Track & Field and Cross Country Coaches Association
- Minnesota Men’s Track and Field Ranked No. 1 for First Time in School History GopherSports.com
- Red Raiders check in at No. 7 in week one rankings – Texas Tech Red Raiders TexasTech.com
- 2023 NCAA DI Women’s Outdoor Track & Field Rating Index – Week 1 U.S. Track & Field and Cross Country Coaches Association
- USTFCCCA Outdoor Rankings – March 27, 2023 – LSU Louisiana State University Athletics
- View Full Coverage on Google News
2023 NCAA DI Men’s Indoor Track & Field Rating Index – Week 6 – U.S. Track & Field and Cross Country Coaches Association
- 2023 NCAA DI Men’s Indoor Track & Field Rating Index – Week 6 U.S. Track & Field and Cross Country Coaches Association
- Top performances in 2023 NCAA indoor track and field …so far NCAA.com
- Trine men complete MIAA indoor 4-peat | Eveningstar | kpcnews.com KPCnews.com
- 2023 NCAA DI Women’s Indoor Track & Field Rating Index – Week 6 U.S. Track & Field and Cross Country Coaches Association
- USTFCCCA Rankings – February 28, 2023 – LSU Louisiana State University Athletics
- View Full Coverage on Google News
Dow Jones Rallies 300 Points On Jobless Claims; Tesla Stock Surges On Reiterated Buy Rating
The Dow Jones Industrial Average rallied 300 points Thursday after initial unemployment claims data from the Labor Department exceeded estimates. And Tesla stock surged as Morgan Stanley reiterated an overweight rating with a reduced price target.
X
Weekly unemployment figures showed first-time claims rose to 225,000 vs. 216,000 in the previous week, higher than Econoday estimates for a rise to 222,000. Claims have been up and down in recent weeks, but generally trending lower since a mid-November high of 241,000.
On the earnings front, chicken egg distribution giant Cal-Maine Foods (CALM) reported Wednesday after the close. Shares declined more than 4% in morning trade. CALM stock ended Wednesday below a 62.74 buy point after two days of losses.
Electric-vehicle leader Tesla (TSLA) raced almost 7% higher Thursday as Morgan Stanley affirmed its overweight rating on the stock, despite a price target cut. Dow Jones tech leaders Apple (AAPL) and Microsoft (MSFT) traded higher after today’s stock market open.
Cardinal Health (CAH), Medpace (MEDP), IBD Leaderboard stock Neurocrine Biosciences (NBIX) and Texas Roadhouse (TXRH) — as well as Dow Jones names Amgen (AMGN), Caterpillar (CAT) and Chevron (CVX) — are among the top stocks to consider for investor watchlists. Keep in mind the recent market weakness should keep investors on the sidelines.
Neurocrine is an IBD Leaderboard stock. Caterpillar and Medpace were recent IBD Stock Of The Day companies. And Cardinal Health is featured in this week’s Stocks Near A Buy Zone column.
IBD’s latest newsletter MarketDiem gives you actionable ideas for stocks, options and crypto right in your inbox
Dow Jones Today: Oil Prices, Treasury Yields
After Thursday’s opening bell, the Dow Jones Industrial Average moved up 0.9%, and the S&P 500 gained 1.4%. The tech-heavy Nasdaq composite rallied 1.8% in morning action.
Among U.S. exchange-traded funds, the Nasdaq 100 tracker Invesco QQQ Trust (QQQ) rose 1.1% and the SPDR S&P 500 ETF (SPY) moved up 0.8% early Thursday.
The 10-year Treasury yield ticked lower to 3.86% Thursday morning, with the yield moving further above its 50-day line after three days of gains.
Meanwhile, U.S. oil prices traded almost 2% lower Thursday, as West Texas Intermediate futures back away from resistance just above $79 a barrel, following a two-week advance. The Energy Information Administration will provide weekly information on oil inventories at 11 a.m. ET.
Stock Market Correction
On Wednesday, the Dow Jones Industrial Average sold off 1.1%, while the S&P 500 dropped 1.2%. The tech-heavy Nasdaq composite was hardest hit, declining 1.35%.
Wednesday’s The Big Picture column commented, “Perhaps more importantly, amid generally quiet trading expected for the remainder of the year, price matters more lately. And the size of the price declines continued to stay weighty. Moreover, the loss of most gains by key equity indexes since an Oct. 21 follow-through day means that it’s still very hard to make money going long.”
Five Dow Jones Stocks To Watch Now
Dow Jones Stocks To Watch: Amgen, Caterpillar, Chevron
Drugmaker Amgen continues to trace a flat base amid a three-week losing streak. And shares are further below their 50-day line after more losses Wednesday. For now, the correct buy point is 296.77, but the stock needs to decisively retake its 50-day first. AMGN stock is up more than 16% for the year through Wednesday. Shares traded 0.5% higher Thursday.
Dow Jones member Caterpillar finished below a 239.95 buy point in a flat base Wednesday, according to IBD MarketSmith pattern recognition. If the stock retakes the entry, the buy zone goes up to 251.95. Bullishly, the stock’s relative strength line, a key technical indicator, is at new highs. CAT stock has a year-to-date gain of almost 16%. Shares moved up 0.5% Thursday.
CAT stock shows a strong 98 out of a perfect 99 IBD Composite Rating, per the IBD Stock Checkup. The Composite Rating is designed to help investors easily find top growth stocks.
Energy giant Chevron is testing its 50-day line amid Wednesday’s 1.5% drop, as the stock continues to trace the right side of a flat base that has a 189.78 buy point. CVX stock is the Dow’s year-to-date leader, up more than 50%. Shares were slightly lower Thursday morning, amid the weakness in oil prices.
4 Top Growth Stocks To Watch In The Current Stock Market Rally
Top Stocks To Watch: Cardinal Health, Medpace, Texas Roadhouse
Cardinal Health, a recent IBD Stock Of The Day, is holding close to a 81.67 buy point in a flat base. Shares declined 0.7% Wednesday. CAH stock was up 0.3% Thursday.
Medpace bounced sharply from its 50-day line last week, with a gain of 3.3%. But the stock gave up a big part of those gains during Tuesday’s 2% fall and is once again trying to find support. For now, the correct buy point looms at 235.82, but an earlier entry at 220.09 is also in play. MEDP stock was up 1.5% Thursday.
Texas Roadhouse shows a new buy point at 101.85 in a flat base, but is now consolidating below its 50-day line. The restaurant leader will look to recover that key benchmark over the coming sessions, but two straight days of sharp losses isn’t constructive. TXRH stock traded up 0.1% Thursday morning.
IBD Leaderboard stock Neurocrine slipped 0.2% Wednesday, again testing support around its 50-day level. A recent bounce off that 50-day line was bullish for the stock’s prospects, but now shares are back at that key area. NBIX stock was up 0.3% Thursday.
Stocks To Watch
These are six top stocks to watch in today’s stock market, including three Dow Jones leaders.
| Company Name | Symbol | Correct Buy Point | Type Of Base |
|---|---|---|---|
| Cardinal Health | (CAH) | 81.67 | Flat base |
| Medpace | (MEDP) | 235.82 | Consolidation |
| Texas Roadhouse | (TXRH) | 101.85 | Flat base |
| Caterpillar | (CAT) | 239.95 | Flat base |
| Chevron | (CVX) | 189.78 | Flat base |
| Amgen | (AMGN) | 296.77 | Flat base |
Source: IBD Data As Of Dec. 28, 2022
Join IBD experts as they analyze leading stocks in the current stock market rally on IBD Live
Tesla Stock
Tesla stock snapped a seven-day losing streak Wednesday, reversing higher and rallying 3.3% after hitting a 52-week low at 108.76. Shares closed about 72% off their 52-week high.
Shares looked to continue their rebound Thursday morning, racing nearly 7% higher.
Late Wednesday, Morgan Stanley analyst Adam Jonas lowered the firm’s price target from 330 to 250, while keeping an overweight rating on TSLA stock. He believes 2023 is “shaping up to be a ‘reset’ year for the EV market,” and Tesla is in position to extend its lead over the competition.
Dow Jones Leaders: Apple, Microsoft
Among Dow Jones stocks, Apple shares sold off 3.1% Wednesday, dropping to 125.87, their lowest level since June 2021. The stock is around 32% off its 52-week high and down 29% since the start of the year. Shares rallied 1.7% Thursday morning, as the Wall Street Journal reported that iPhone production in China was ramping up after Covid-19 issues.
Microsoft stock dropped 1% Wednesday, falling further below the 50-day line. The software giant is about 32% off its 52-week high with a year-to-date loss of more than 30%. MSFT stock moved up 0.8% early Thursday.
Be sure to follow Scott Lehtonen on Twitter at @IBD_SLehtonen for more on growth stocks and the Dow Jones Industrial Average.
YOU MAY ALSO LIKE:
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
MarketSmith: Research, Charts, Data And Coaching All In One Place
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
VMware bug with 9.8 severity rating exploited to install witch’s brew of malware
Hackers have been exploiting a now-patched vulnerability in VMware Workspace ONE Access in campaigns to install various ransomware and cryptocurrency miners, a researcher at security firm Fortinet said on Thursday.
CVE-2022-22954 is a remote code execution vulnerability in VMware Workspace ONE Access that carries a severity rating of 9.8 out of a possible 10. VMware disclosed and patched the vulnerability on April 6. Within 48 hours, hackers reverse-engineered the update and developed a working exploit that they then used to compromise servers that had yet to install the fix. VMware Workspace ONE access helps administrators configure a suite of apps employees need in their work environments.
In August, researchers at Fortiguard Labs saw a sudden spike in exploit attempts and a major shift in tactics. Whereas before the hackers installed payloads that harvested passwords and collected other data, the new surge brought something else—specifically, ransomware known as RAR1ransom, a cryptocurrency miner known as GuardMiner, and Mirai, software that corrals Linux devices into a massive botnet for use in distributed denial-of-service attacks.
FortiGuard
“Although the critical vulnerability CVE-2022-22954 is already patched in April, there are still multiple malware campaigns trying to exploit it,” Fortiguard Labs researcher Cara Lin wrote. Attackers, she added, were using it to inject a payload and achieve remote code execution on servers running the product.
The Mirai sample Lin saw getting installed was downloaded from http[:]//107[.]189[.]8[.]21/pedalcheta/cutie[.]x86_64 and relied on a command and control server at “cnc[.]goodpackets[.]cc. Besides delivering junk traffic used in DDoSes, the sample also attempted to infect other devices by guessing the administrative password they used. After decoding strings in the code, Lin found the following list of credentials the malware used:
|
hikvision |
1234 |
win1dows |
S2fGqNFs |
|
root |
tsgoingon |
newsheen |
12345 |
|
default |
solokey |
neworange88888888 |
guest |
|
bin |
user |
neworang |
system |
|
059AnkJ |
telnetadmin |
tlJwpbo6 |
iwkb |
|
141388 |
123456 |
20150602 |
00000000 |
|
adaptec |
20080826 |
vstarcam2015 |
v2mprt |
|
Administrator |
1001chin |
vhd1206 |
support |
|
NULL |
xc3511 |
QwestM0dem |
7ujMko0admin |
|
bbsd-client |
vizxv |
fidel123 |
dvr2580222 |
|
par0t |
hg2x0 |
samsung |
t0talc0ntr0l4! |
|
cablecom |
hunt5759 |
epicrouter |
zlxx |
|
pointofsale |
nflection |
admin@mimifi |
xmhdipc |
|
icatch99 |
password |
daemon |
netopia |
|
3com |
DOCSIS_APP |
hagpolm1 |
klv123 |
|
OxhlwSG8 |
In what appears to be a separate campaign, attackers also exploited CVE-2022-22954 to download a payload from 67[.]205[.]145[.]142. The payload included seven files:
- phpupdate.exe: Xmrig Monero mining software
- config.json: Configuration file for mining pools
- networkmanager.exe: Executable used to scan and spread infection
- phpguard.exe: Executable used for guardian Xmrig miner to keep running
- init.ps1: Script file itself to sustain persistence via creating scheduled task
- clean.bat: Script file to remove other cryptominers on the compromised host
- encrypt.exe: RAR1 ransomware
In the event RAR1ransom has never been installed before, the payload would first run the encrypt.exe executable file. The file drops the legitimate WinRAR data compression executable in a temporary Windows folder. The ransomware then uses WinRAR to compress user data into password-protected files.
The payload would then start the GuardMiner attack. GuardMiner is a cross-platform mining Trojan for the Monero currency. It has been active since 2020.
The attacks underscore the importance of installing security updates in a timely manner. Anyone who has yet to install VMware’s April 6 patch should do so at once.
How unhealthy is red meat? And how beneficial is it to eat vegetables? A new rating system could help you cut through the health guidelines
The Research Brief is a short take about interesting academic work.
The big idea
We developed a new method for assessing health risks that our research suggests should make it a lot easier for people to determine which health advice to follow – and which to ignore. The approach, recently published in the journal Nature Medicine, offers a straightforward way for both policymakers and the general public to assess the strength of evidence for a given health risk – like consuming red meat – and the corresponding outcome – ischemic heart disease – using a rating system of one to five stars.
The system we developed is based on several systematic reviews of studies regarding risk factors like smoking and health outcomes such as lung cancer. Well-established relationships between risks and outcomes score between three and five stars, whereas cases in which research evidence is lacking or contradictory garner one to two stars.
In our analysis, only eight of the 180 pairs that we analyzed received the top rating of five stars, indicating very strong evidence of association. The relationship between smoking and lung cancer, as well as the relationship between high systolic blood pressure – the higher of the two numbers in a blood pressure reading – and ischemic heart disease were among those eight five-star pairs.
This rating system enables consumers to easily identify how harmful or protective a behavior may be and how strong the evidence is for each risk-outcome pair. For instance, a consumer seeing a low star rating can use that knowledge to decide whether to shift a health habit or choice.
In addition, we created an online, publicly available visualization tool that displays 50 risk-outcome pairs that we discussed in five recently published papers in Nature Medicine.
While the visualization tool provides a nuanced understanding of risk across the range of blood pressures, the five-star rating signals that the overall evidence is very strong. As a result, this means that clear guidelines can be given on the importance of controlling blood pressure.
Why it matters
Clear messages and evidence-based guidance regarding healthy behaviors are crucial. Yet health guidance is often contradictory and difficult to understand.
Currently, most epidemiological analyses make strong assumptions about relationships between risks and health outcomes, and study results often disagree as to the strength of risk-outcome relationships. It can be confusing for experts and nonexperts alike to parse through conflicting studies of varying strength of results and determine if a lifestyle change is needed.
This is where our method comes in: The star-based rating system can offer decision-makers and consumers alike much-needed context before headline-grabbing health guidance is dispensed and adopted.
For example, the average risk of ischemic heart disease with a blood pressure of 165 mmHG – or millimeters of mercury, the basic unit used for measuring pressure – is 4.5 times the risk of the disease with blood pressure of 100 mmHG; but this is just a single estimate. The relative risk of ischemic heart disease increases by more than four times across the blood pressure range, and there is inherent uncertainty in the estimate based on available data. The rating of five stars incorporates all of this information, and in this case means that relative risk of ischemic heart disease across the entire range of exposures increases by at least 85%.
On the other hand, take the example of red meat consumption. Consuming just 100 grams of red meat per day – as opposed to none – results in a very modest (12%) increase in risk for ischemic heart disease. That’s why it scores a rating of just two stars, consistent with only a weak association.
People should be well aware of their levels of exposure to risks classified with three to five stars, such as systolic blood pressure. By monitoring and keeping one’s blood pressure as low as possible, a person can substantially reduce the risk of developing ischemic heart disease.
What’s next
Our hope is that decision-makers will be able to use our star rating system to create informed policy recommendations that will have the greatest benefits for human health. We also hope the public can use the ratings and the visualization tool tool as a way to more clearly understand the current level of knowledge for different pairs of health risks and outcomes.
This article is republished from The Conversation, an independent nonprofit news site dedicated to sharing ideas from academic experts. It was written by: Aleksandr Aravkin, University of Washington; Christian Razo, University of Washington, and Jeffrey Stanaway, University of Washington. If you found it interesting, you could subscribe to our weekly newsletter.
Read more:
Jeffrey Stanaway receives funding from the Bill and Melinda Gates Foundation.
Aleksandr Aravkin and Christian Razo do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.